OCULAR ADVERSE EVENTS ASSOCIATED WITH PROGRAMMED DEATH-1 AND PROGRAMMED DEATH LIGAND-1 IMMUNOTHERAPY

被引：0
|
作者：
Young, LeAnne [1 ]
Finnigan, Shanda [2 ]
Streicher, Howard [2 ]
Chen, Helen [2 ]
Murray, James [2 ]
Sen, H. Nida [1 ]
Sharon, Elad [2 ]
机构：
[1] NEI, Cleveland, OH USA
[2] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0644
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
644
引用
收藏
页码：A386 / A387
页数：2
相关论文
共 50 条
  • [41] Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1
    Hsu, Jun-Te
    Hsu, Chih-Sin
    Le, Puo-Hsien
    Chen, Tse-Ching
    Chou, Wen-Chi
    Lin, Chun-Yen
    Yeh, Ta-Sen
    JOURNAL OF SURGICAL RESEARCH, 2017, 211 : 30 - 38
  • [42] Fatal adverse events associated with programmed cell death protein 1 or programmed cell death-ligand 1 monotherapy in cancer
    Zhao, Bin
    Zhao, Hong
    Zhao, Jiaxin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [43] Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis
    Quan, Hongzhi
    Liu, Sixuan
    Shan, Zhongyan
    Liu, Ziyi
    Chen, Tianjun
    Hu, Yanjia
    Yao, Zhigang
    Fang, Liangjuan
    ARCHIVES OF ORAL BIOLOGY, 2020, 119
  • [44] Adverse events associated with "Anti-programmed death-1" therapy for patients with melanoma
    De Francesco, Adele Emanuela
    De Fina, Mariarosanna
    Zito, Maria Cristina
    Bisceglia, Maria Dezia
    Esposito, Stefania
    Fersini, Giuseppina
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [45] Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review (vol 23, 86, 2021)
    Smith, Caleb J.
    Almodallal, Yahya
    Jatoi, Aminah
    CURRENT ONCOLOGY REPORTS, 2021, 23 (08)
  • [46] Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1
    Zhao Jing
    Huang Jian
    中华医学杂志英文版, 2020, 133 (07) : 853 - 862
  • [47] Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
    Banerjee, Debasree
    Monaghan, Sean
    Zhao, Runping
    Walsh, Thomas
    Palmisciano, Amy
    Phillips, Gary S.
    Opal, Steven
    Levy, Mitchell M.
    CRITICAL CARE, 2018, 22
  • [48] Expression of programmed death ligand-1 and programmed death 1 in hepatocellular carcinoma and its clinical significance
    Long, J.
    Qu, Tao
    Pan, X. F.
    Tang, X.
    Wan, H. H.
    Qiu, P.
    Xu, Yan-Hua
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S1188 - S1192
  • [49] Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
    Debasree Banerjee
    Sean Monaghan
    Runping Zhao
    Thomas Walsh
    Amy Palmisciano
    Gary S. Phillips
    Steven Opal
    Mitchell M. Levy
    Critical Care, 22
  • [50] Inhibition of Programmed Death Receptor-1/Programmed Death Ligand-1 Interactions by Ginsenoside Metabolites
    Yim, Nam-Hui
    Kim, Young Soo
    Chung, Hwan-Suck
    MOLECULES, 2020, 25 (09):
12345